Enliven Therapeutics (ELVN) Total Current Liabilities (2019 - 2026)
Enliven Therapeutics' Total Current Liabilities came in at $14.16 million for Q2 2026, down 6.9% from $15.21 million a year earlier but up 23.3% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Total Current Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2025, Enliven Therapeutics' Total Current Liabilities was $16.57 million, up 4.1% from FY2024.
- Total Current Liabilities carries a five-year compound annual growth rate of 21.5% (FY2020 to FY2025).
- Going back by year, Total Current Liabilities was $15.92 million in FY2024 (-38.5%), $25.89 million in FY2023 (+166.5%), $9.72 million in FY2022 (+34.7%) and $7.21 million in FY2021 (+15.4%).
- The five-year range for quarterly Total Current Liabilities is $1.82 million (Q3 2022) to $25.89 million (Q4 2023).
- Year-over-year, Total Current Liabilities increased in two of the last eight quarters, with an average decline of 13.4%.
- The fastest year-over-year change in Total Current Liabilities over five years came in Q3 2023 (growth of 564.4%), and the weakest in Q3 2022 (a decline of 74.7%).
- Business Quant data shows ELVN's Total Current Liabilities at $11.49 million (Q1 2026), $16.57 million (Q4 2025) and $14.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.08 Bn | 1,101.67 Bn | 19.71 Bn | 47.74 Bn |
| 2 | Johnson & Johnson | 616.40 Bn | 534.93 Bn | 17.26 Bn | 54.90 Bn |
| 3 | AbbVie | 501.19 Bn | 474.31 Bn | 12.70 Bn | 41.64 Bn |
| 4 | Merck | 367.18 Bn | 321.56 Bn | 12.21 Bn | 27.73 Bn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 31.75 Bn |
| 6 | Astrazeneca | 261.67 Bn | 235.36 Bn | 12.86 Bn | 31.55 Bn |
| 7 | Amgen | 235.57 Bn | 190.97 Bn | 7.24 Bn | 25.50 Bn |
| 8 | Gilead Sciences | 190.62 Bn | 164.82 Bn | 6.22 Bn | 11.02 Bn |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn | 32.65 Bn |
| 10 | Enliven Therapeutics | 2.80 Bn | 513.30 Mn | - | 14.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.16 Mn |
| Mar 31, 2026 | 11.49 Mn |
| Dec 31, 2025 | 16.57 Mn |
| Sep 30, 2025 | 14.65 Mn |
| Jun 30, 2025 | 15.21 Mn |
| Mar 31, 2025 | 13.97 Mn |
| Dec 31, 2024 | 15.92 Mn |
| Sep 30, 2024 | 17.03 Mn |
| Jun 30, 2024 | 22.11 Mn |
| Mar 31, 2024 | 25.03 Mn |
| Dec 31, 2023 | 25.89 Mn |
| Sep 30, 2023 | 12.08 Mn |
| Jun 30, 2023 | 9.15 Mn |
| Mar 31, 2023 | 10.94 Mn |
| Dec 31, 2022 | 9.72 Mn |
| Sep 30, 2022 | 1.82 Mn |
| Jun 30, 2022 | 3.30 Mn |
| Mar 31, 2022 | 7.22 Mn |
| Dec 31, 2021 | 7.21 Mn |
| Sep 30, 2021 | 7.19 Mn |
API Access
Enliven Therapeutics Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();